Australia's most trusted
source of pharma news
Posted 21 November 2023 AM
At least seven drugs recommended for approval at the CHMP's November meeting have already entered Australia's regulatory process, signalling that the TGA may make a similar decision soon.
Most of the recommendations cover new indications for existing drugs such as MSD's Keytruda combination therapy for biliary tract carcinoma.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.